Does CAPLACIZUMAB-YHDP Cause Off label use? 133 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 133 reports of Off label use have been filed in association with CAPLACIZUMAB-YHDP. This represents 9.5% of all adverse event reports for CAPLACIZUMAB-YHDP.
133
Reports of Off label use with CAPLACIZUMAB-YHDP
9.5%
of all CAPLACIZUMAB-YHDP reports
1
Deaths
26
Hospitalizations
How Dangerous Is Off label use From CAPLACIZUMAB-YHDP?
Of the 133 reports, 1 (0.8%) resulted in death, 26 (19.5%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB-YHDP. However, 133 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB-YHDP Cause?
Product use in unapproved indication (465)
Adamts13 activity decreased (136)
Platelet count decreased (126)
Epistaxis (123)
Fatigue (110)
Contusion (86)
Injection site pain (74)
Headache (71)
Adamts13 activity abnormal (63)
Injection site bruising (63)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which CAPLACIZUMAB-YHDP Alternatives Have Lower Off label use Risk?
CAPLACIZUMAB-YHDP vs CAPMATINIB
CAPLACIZUMAB-YHDP vs CAPREOMYCIN
CAPLACIZUMAB-YHDP vs CAPSAICIN
CAPLACIZUMAB-YHDP vs CAPTOPRIL
CAPLACIZUMAB-YHDP vs CARBAMAZEPINE